Quinine

Alkaloids

NP0512

130-95-0

Quinine

Quinine is isolated from the barks of Cinchona ledgeriana (Howard) Moens ex Trim. It is used for the treatment of acute malaria in pregnant women.

Quinine;130-95-0;Chinin;Chinine;(-)-Quinine;6'-Methoxycinchonidine;(8S,9R)-Quinine;Quinine anhydrous;(R)-(-)-quinine;chininum;quinina;Qualaquin;Quinine, Anhydrous;6-Methoxycinchonine;Rezquin;Chininum purum;quinine bisulphate;Cinchonan-9-ol, 6'-methoxy-, (8alpha,9R)-;(8S,9R)-6'-Methoxycinchonan-9-ol;quinine sulfate;CHEBI:15854;(8-alpha,9R)-6'-Methoxycinchonan-9-ol;UNII-A7V27PHC7A;A7V27PHC7A;Aflukin;NSC 192949;CCRIS 5755;Coco-Quinine;(R)-(-)-Quinine, 6-methoxycinchonidine;DTXSID0044280;HSDB 2501;Quinoline alkaloid;EINECS 205-003-2;MFCD00198096;NSC-192949;Quinine sulphate;(R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol;WR297608;(9R)-6'-methoxy-8alpha-cinchonan-9-ol;(R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol;Cinchonan-9-ol, 6'-methoxy-;6'-Methoxycinchonan-9-ol;DTXCID60819897;EC 205-003-2;GNF-Pf-506;NSC192949;(R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol;2-Quinuclidinemethanol, alpha-(6-methoxy-4-quinolyl)-5-vinyl-;NSC 5362;QUININE (MART.);QUININE [MART.];Quinine, tannate;(R)-(6-Methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methanol;Chinin [German];Cinchonan-9-ol, 6'-methoxy-, (8-alpha,9R)-;72402-53-0;Quinineanhydrous;Kinder Quinina;(R)-[(2S,4S,5R)-1-Aza-5-vinylbicyclo[2.2.2]-oct-2-yl](6-methoxyquinolin-4-yl)methanol;CAS-130-95-0;6'-Methoxycinchonine;NSC667852;Quinine [BAN:NF];CHEMBL170;Quinine tannate [USP];Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-;UNII-26MX5YAL2R;Quinsan;Cinchonan-9-ol, 6'-methoxy-, (8a,9R)-;(-)quinine;NCGC00166281-01;QI9;EINECS 215-805-4;NSC5362;Dentojel (*Bisulfate heptathydrate*);Biquinate (*Bisulfate heptathydrate*);Quinine, 90%;Quine (*2:1 Sulfate salt*, dihydrate);QUININE [VANDF];QUININE [HSDB];(8.alpha.,9R)-6'-Methoxycinchonan-9-ol;Quinamm (*2:1 Sulfate salt*), dihydrate;Quinsan (*2:1 Sulfate salt*), dihydrate;QUININE [MI];QUININE [WHO-DD];Epitope ID:131786;SCHEMBL27031;CHININUM PURUM [HPUS];GTPL2510;alpha-(6-Methoxy-4-quinoyl)-5-vinyl-2-quinclidinemethanol;Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-, sulfate;HMS2089E05;STR03990;Tox21_112389;BDBM50367247;s4495;AKOS017343662;Tox21_112389_1;DB00468;NCGC00166281-06;NCGC00274071-01;NS00002397;(3alpha,8alpha,9R)-6'-methoxycinchonan-9-ol;EN300-258513;O12066;AB00375052-11;AB00375052-12;AB00375052_13;Q189522;Quinine, certified reference material, TraceCERT(R);BRD-K07940445-003-01-2;Q27166273;Z2235811384;(R)-(6-methoxy-4-quinolyl)-[(2S,4S,5R)-5-vinylquinuclidin-2-yl]methanol;(R)-(6-methoxyquinolin-4-yl)((2S,4S,5R)-5-vinylquinuclidin-2-yl)methanol;(1R)-(6-methoxyquinolin-4-yl)((2S,4S,5R)-5-vinylquinuclidin-2-yl)methanol;(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxy-4-quinolinyl)methanol;(R)-[(2S,4S,5R)-1-Aza-5-vinylbicyclo[2.2.2]oct-2-yl](6-methoxyquinolin-4-yl)methanol;Quinine, suitable for fluorescence, anhydrous, >=98.0% (dried material, NT);(R)-[(1S,2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol;(R)-[(4S,5R,7S)-5-ethenyl-1-azabicyclo[2.2.2]octan-7-yl]-(6-methoxyquinolin-4-yl)methanol;

(R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol

324.42

C20H24N2O2

O[C@H](C1=CC=NC2=C1C=C(OC)C=C2)[C@@]3([H])[N@](C[C@@H]4C=C)CC[C@H]4C3

InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19-,20+/m0/s1

LOUPRKONTZGTKE-WZBLMQSHSA-N

495.9±40.0 °C at 760 mmHg

173-175 °C(lit.)

253.7°C

97%

1.2±0.1 g/cm3

H2O: soluble

Cryst.

antimalarial

2 month in rt, long time

Please store the product under the recommended conditions in the Certificate of Analysis.

Yellow

Powder

MFCD00198096

pH of saturated aqueous solution = 8.8;

1.625 (15°C)

Stable under normal temperatures and pressures. May discolor on exposure to light.

1.54X10-10 mm Hg at 25 deg C (est);

1